CLINICAL_TRIALS
trial_result
· 2025-09-29
Clinical Trial Update: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Summary
A clinical trial evaluating Abrocitinib in adults with moderate to severe atopic dermatitis has been terminated, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Status: TERMINATED | Results posted: 2025-09-29